CATHETER ABLATION OF CHRONIC ATRIAL FIBRILLATION IN A PATIENT WITH HYPERTROPHIC CARDIOMYOPATHY
Abstract
The clinical case report is presented of the successful catheter ablation of chronic atrial fibrillation in a 48 year old patient with hypertrophic cardiomyopathy and considerable enlargement of the left atrium.
About the Authors
D. S. Lebedev
ФГУ «Федеральный центр сердца, крови и эндокринологии им. В.А.Алмазова федерального агентства по высокотехнологичной медицинской помощи», Санкт-Петербург
Russian Federation
Russian Federation
E. N. Mikhailov
ФГУ «Федеральный центр сердца, крови и эндокринологии им. В.А.Алмазова федерального агентства по высокотехнологичной медицинской помощи», Санкт-Петербург
Russian Federation
Russian Federation
S. V. Gureev
ФГУ «Федеральный центр сердца, крови и эндокринологии им. В.А.Алмазова федерального агентства по высокотехнологичной медицинской помощи», Санкт-Петербург
Russian Federation
Russian Federation
N. V. Sviridova
ФГУ «Федеральный центр сердца, крови и эндокринологии им. В.А.Алмазова федерального агентства по высокотехнологичной медицинской помощи», Санкт-Петербург
Russian Federation
Russian Federation
V. K. Lebedeva
ФГУ «Федеральный центр сердца, крови и эндокринологии им. В.А.Алмазова федерального агентства по высокотехнологичной медицинской помощи», Санкт-Петербург
Russian Federation
Russian Federation
References
1. Cecchi F, Olivotto I, Montereggi A, Santoro G et al. Hypertrophic cardiomyopathy in Tuscany: Clinical course and outcome in an unselected regional population // J. Am. Coll. Cardiol. - 1995. - V.26. - P.1529-36.
2. Gruver E.J., Fatkin D., Dodds D.A. et al. Familial hypertrophic cardiomyopathy and atrial fibrillation caused by Arg663His beta-cardiac myosin heavy chain mutation // Am. J. Cardiol. - 1999. - V.83. - P.13H-8H.
3. Herweg B, Sichrovsky T, Polosajian L. et. al. Hypertension and hypertensive heart disease are associated with increased ostial pulmonary vein diameter // J. Cardiovasc. Electrophysiol. - 2005. - V.16. - P.2-5.
4. Herweg B, Sichrowsky T, Polosajian L. et. al. Pulmonary vein diameter is increased in patients with paroxysmal atrial fibrillation compared to aged matched controls // J. Am. Coll. Cardiol. - 2002. - V.39 (Suppl). - 116A (abstr.).
5. Maron B.J., McKenna W.J., Dantelson G.K. et al. ACC/ ESC Clinical expert consensus document on hypertrophyc cardiomyopathy: a report of the American College of Cardiology foundation task force on clinical expert consensus documents and the European Society of Cardiology committee for practice guidelines // Eur. Heart J. - 2003. - V.24. - P.1961-1991.
6. Maron BJ, Gardin JM, Flack JM. et. al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA Study // Circulation. - 1995. - V.92. - P. 785-9.
7. Robinson K, Frenneaux MP, Stockins B. et. al. Atrial fibrillation in hypertrophic cardiomyopathy: A longitudinal study // J. Am. Coll. Cardiol. - 1990. - V.15. - P.1279-85.
8. Calkins H., Brugada J., Packer D.L. et al. HRS/EHRA/ ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation // Heart Rhythm. - 2007. - V4(6). - P.816-61.
9. Fuster V, Ryden LE, Cannom DS. et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation - a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) // J. Am. Coll. Cardiol. - 2006. -V.48. - P. e149-246.
10. Gaita F, Di Donna P, Olivotto I. Usefulness and safety of transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy // Am. J. Cardiol. - 2007. -V.1; 99(11). - P.1575-81.
11. Jais P, Cauchemez B, MacLe L. et al. Atrial fibrillation ablation vs antiarrhythmic drugs: A multicenter randomized trial // Heart Rhythm. - 2006. - V.3. - P.S1-S460.
12. Kilicaslan F, Verma A, Saad E. et. al. Efficacy of catheter ablation of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy // Heart Rhythm. - 2006. - V.3(3). - P.275-80.
13. Pappone C, Augello G, Sala S. et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study // J. Am. Coll. Cardiol. - 2006. -V.48. - P.2340 -2347.
14. Pappone C, Rosanio S, Augello G. et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study // J. Am. Coll. Cardiol. - 2003. - V.42. - P.185-197.
15. Wazni OM, Marrouche NF, Martin DO. et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial // JAMA. - 2005. - V.293. - P.2634 -2640.
Review
For citations:
Lebedev D.S., Mikhailov E.N., Gureev S.V., Sviridova N.V., Lebedeva V.K. CATHETER ABLATION OF CHRONIC ATRIAL FIBRILLATION IN A PATIENT WITH HYPERTROPHIC CARDIOMYOPATHY. Journal of Arrhythmology. 2008;51(51):72-74. (In Russ.)
Views:
138
Email this article 